The known unknowns of T cell immunity to COVID-19

Karlsson, Annika C., Humbert, Marion, Buggert, Marcus·2020·Science Immunology
DOI 10.1126/sciimmunol.abe8063

Cited by (165)

Items 101–165 of 165

  1. Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study
    Annika Fendler, Lewis Au, Laura Amanda Boos, Fiona Byrne, Scott T.C. Shepherd, Ben Shum, Camille L. Gerard, Barry Ward, Wenyi Xie, Maddalena Cerrone et al. · 2020 · medRxiv
  2. COVID-19’s Impact on Athletes: Reduced Cardiorespiratory Fitness after a SARS-CoV-2 Infection
    Erik Häsler, Manuel Widmann, Bernhard Haller, Roman Gaidai, Andreas Venhorst, Tim Meyer, Claus Reinsberger, Andreas Michael Niess, Kai Röecker · 2024 · Medicine & Science in Sports & Exercise
  3. Cervical sympathetic block to treat Long COVID: a scoping review
    Anna Maria Bombardieri, Claudia Florez Denoue · 2025 · Regional Anesthesia & Pain Medicine
  4. Exploratory Study on Micronuclei and Metanuclear Abnormalities in Exfoliated Buccal Cells of COVID-19 Suspected Patients
    B Vishnu, Senthil Murugan, Vinoth Kumar Kalidoss, Kishore Sesham, Sarah Ramamurthy, Satvinder Singh Bakshi, Yuvaraj Maria Francis, Sankaran Ponnusamy Kasirajan · 2023 · Journal of Cytology
  5. Organbezogene Folgeerscheinungen von COVID‑19 bei Erwachsenen
    Jan K. Hennigs, Tim Oqueka, Lars Harbaum, Hans F. E. Klose · 2022 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  6. T cell receptor repertoire signatures associated with COVID-19 severity
    Jonathan Joon-Young Park, Kyoung A. Viola Lee, Stanley Z. Lam, Sidi Chen · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  7. SARS-CoV-2 Infection, Post COVID-19 Symptoms and Acupuncture
    Joseph F. Audette · 2022 · Medical Acupuncture
  8. Identification of Putative Serum Autoantibodies Associated with Post-Acute Sequelae of COVID-19 via Comprehensive Protein Array Analysis
    Yasuyoshi Hatayama, Kei Miyakawa, Yayoi Kimura, Kazuo Horikawa, Kouichi Hirahata, Hirokazu Kimura, Hideaki Kato, Atsushi Goto, Akihide Ryo · 2025 · International Journal of Molecular Sciences
  9. Post-Covid-19 Immunological Disorder: A Possible Pathological Entity in a 43 Year Old Man
    Gabriel Scarlat, Bassil Dona, Bianca Procopiescu, Marilena Stoian · 2022 · Internal Medicine
  10. Sequential Administration of SARS-CoV-2 Strains-Based Vaccines Effectively Induces Potent Immune Responses against Previously Unexposed Omicron Strain
    Qianying Wang, Shuhui Wang, Ying Liu, Shuo Wang, Hong Peng, Yanling Hao, Kunxue Hong, Dan Li, Yiming Shao · 2023 · Pathogens
  11. Analyzing the Interplay between COVID-19 Viral Load, Inflammatory Markers, and Lymphocyte Subpopulations on the Development of Long COVID
    Andrea Rivera-Cavazos, José Antonio Luviano-García, Arnulfo Garza‐Silva, Devany Paola Morales-Rodríguez, Mauricio Kuri-Ayache, Miguel Ángel Sanz‐Sánchez, Juan Enrique Santos-Macías, María Elena Romero-Ibarguengoitia, Arnulfo González‐Cantú · 2023 · Microorganisms
  12. Have Previous COVID-19 Vaccinations Shaped the Potential Enhancing Infection of Variant Strains?
    Husheng Xiong, Xiang Meng, Yanqin Song, Jiayi Zhong, Shuang Liu, Xun Zhu, Xin Ye, Yonghui Zhong, Dingmei Zhang · 2024 · Vaccines
  13. Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates
    Aysha Alkhemeiri, Ziad El‐Khatib, Ali Al-Ameri, Athari Ahmed AlKaabi, Lakshmanan Jeyaseelan, Niyi Awofeso · 2025 · Journal of Epidemiology and Global Health
  14. National Population-Level Disparities in COVID-19 Mortality Across the Intersection of Race/Ethnicity and Sex in the United States
    Jay J. Xu, Jarvis T. Chen, Thomas R. Belin, Ronald Brookmeyer, Marc A. Suchard, Christina M. Ramirez · 2021 · medRxiv
  15. Association between mental health symptoms and autoimmunity in patients with long COVID
    Hernan Felipe Guillen-Burgos, Mauricio Sarmiento, Juan Francisco Galvez-Florez, Catalina Rojas, Yaneth Beatriz Lora, Iván David Lozada-Martínez, Maria Carolina Diazgranados-Garcia, GIBACUS, Manuel Rojas, Juan Carlos Salazar-Uribe et al. · 2025 · BMC Infectious Diseases
  16. Neutralizing antibodies and T-cell responses to inactivated SARS-CoV-2 vaccine in COVID-19 convalescents one and a half years after infection
    Lina Yan, Dan Li, Zhendong Wang, Zezheng Jiang, Xiao Xiao, Xue‐jie Yu · 2022 · Virus Research
  17. Therapeutic Potential of Propolis Extract in Managing Hyperinflammation and Long COVID‐19: A Bioinformatics Study
    Isa Anshori, Donny Marcius, Putri Hawa Syaifie, Khalish Arsy Al Khairy Siregar, Luqman Abdan Syakuran, Muhammad Miftah Jauhar, Adzani Gaisani Arda, Wervyan Shalannanda, Etik Mardliyati · 2024 · Chemistry & Biodiversity
  18. Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection
    Zdzisława Kondera‐Anasz, Emilia Morawiec, Roksana Duszkiewicz, Filip Hajdrowski, Andrzej Wiczkowski · 2025 · Frontiers in Immunology
  19. The use of inhaled tauractant therapy in the subacute period of COVID-19
    Воронкова Ольга Олеговна, A. A. Starzhevskaya, V. G. Skachek, E. F. Rogova, Абдуллаева Гульнара Бурхановна, Буянова Ольга Евгеньевна, Maria V. Kozhevnikova, Yu. N. Belenkov · 2023 · Meditsinskiy sovet = Medical Council
  20. Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June–November 2020)
    Gabriel Fabricius, R. A. Borzi, José Caminos, Tomás S. Grigera · 2022 · Epidemiology and Infection
  21. Invention and Innovation
    David Dent · 2024 · Springer eBooks
  22. Pre-Existing Cellular Immunity to SARS-CoV-2 Through an Immunodominant Epitope
    Katie E. Lineburg, Emma J. Grant, Srividhya Swaminathan, Demetra S.M. Chatzileontiadou, Christopher W. Szeto, Hannah Sloane, Archana Panikkar, Jyothy Raju, Pauline Crooks, Sweera Rehan et al. · 2021 · SSRN Electronic Journal
  23. Multiparametric analysis of the specific immune response against SARS-CoV-2
    Lucie Vránová, Ingrid Poláková, Šárka Vaníková, Martina Saláková, Jan Musil, Marie Vaníčková, Ondřej Vencálek, Michal Holub, Miloš Bohoněk, David Řezáč et al. · 2024 · Scandinavian Journal of Infectious Diseases
  24. Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.
    Jisun Lee, Bomi Kim, Hye-Min Woo, Jun-Won Kim, In-Whoan Jung, Seong-Wook Park, Yong-Sung Kim, Jung-Hyun Na, Sang Taek Jung · 2024 · Molecular Pharmaceutics
  25. Pathogenesis of covid-19: principles of viral infection and immune response
    Jiří Beneš, Dana Nováková · 2021 · Intervenční a akutní kardiologie
  26. Sağlık Çalışanları SARS-CoV-2 Hasta Kohordunda Antikor Sürdürülebilirliği
    Erhan Eser, Şebnem Şenol Akar, Sinem Akçalı, Talat Ecemiş, Pınar Erbay Dündar, Kübra Çiçek, Damla Akman, Ecem Tüzün, Gülsüm ŞANLI ERKEKOĞLU, Zeynep Ceyda Buran et al. · 2022 · Mikrobiyoloji Bulteni
  27. Laboratory Findings in Different Disease Status of COVID-19 Admitted Patients at Dilla University Referral Hospital Treatment Center, South Ethiopia
    Gemechu Churiso, Kuma Diriba, Henok Girma, Soressa Tafere · 2022 · Infection and Drug Resistance
  28. How immunosuppressive therapy impaires on COVID-19 mRNA-vaccine response in rheumatic diseases
    Marta Priora, Simone Parisi, Valentina BENEDETTI, Enrico Fusaro · 2022 · Minerva Medica
  29. Science’s Response to COVID-19
    Yimon Aye, Marcus J. C. Long · 2021 · Preprints.org
  30. Third dose vaccine With BNT162b2 and its response on Long COVID after Breakthrough infections
    Ashraful M. Hoque, Md Marufur Rahman, Hossain Imam, Nurun Nahar, Forhad Uddin Hasan Chowdhury · 2021 · medRxiv
  31. COVID-19 en los trabajadores de salud del Instituto Autónomo Hospital Universitario de Los Andes en Mérida, Venezuela
    José Manuel Barboza, Jormany Quintero, Angélica Sivira, Lenín Constantino Valeri-Ramírez, Eneida Rosa Eneida Rosa, Ciro Antonio Angulo-Lacruz · 2021 · Investigación Clínica
  32. Neurologische Manifestationen des Post-COVID-Syndroms
    Steven Drahn · 2021 · CardioVasc
  33. Peer Review #1 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"
    2021 · PeerJ
  34. Peer Review #3 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"
    2021 · PeerJ
  35. Peer Review #1 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.2)"
    2021 · PeerJ
  36. Peer Review #2 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"
    2021 · PeerJ
  37. The ATLAS™ screening assay reveals distinct CD4 + and CD8 + SARS-CoV-2 antigen response profiles which have implications to Omicron cellular immunity
    James J. Foti, Kevin Lema, Justin Strickland, Emily C. Tjon, Adrienne Li, Amalia Rivera, Crystal Cabral, Laura Cormier, Louisa M. Dowal, Sudhir Rao et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Immunological characteristics of CoVID-19 and its implications
    Amrita Ghosh, Ranabir Pal, RayElizabeth Dominic, Mugdha Mittal, Luis Rafael Moscote‐Salazar, BukkambudhiV Murlimanju, Rafael Cincu, Amit Agrawal · 2022 · Indian Journal of Health Sciences and Biomedical Research (KLEU)
  39. Post-Covid-19 Immunological Disorder: A Possible Pathological Entity in a 43 Year Old Man
    Gabriel Scarlat, Marilena Stoian · 2022 · Journal of Medicine and HealthCare
  40. Nasal anti-CD3 mAb (Foralumab) dampens CD3+ T effector function and decreases NKG7 in COVID-19 through a mechanism involving GIMAP-7 and TGFb1
    Thaís Garcias Moreira, Christian D. Gauthier, Liam Murphy, Toby Black Lanser, Anu Paul, Kimble Teixeira Fonseca Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C. Healy et al. · 2022 · Research Square
  41. Pulmonary Sequelae of COVID-19
    Zubair Hasan, Abhinav Agrawal, Mangala Narasimhan · 2022 · Springer eBooks
  42. COVID-19 İmmünopatogenezi
    İsmihan Sunar, Kemal Nas · 2023
  43. Características sociodemográficas, clínicas, epidemiológicas, funcionales y de calidad de vida de pacientes con COVID-19 y COVID persistente
    Rodrigo Vélez-Santamaría · 2023
  44. OUTCOME OF PULMONARY REHABILITATION IN LONG COVID PATIENTS ATTENDING TERTIARY LEVEL HOSPITAL OF BANGLADESH
    2024 · International Research Journal of Modernization in Engineering Technology and Science
  45. INTERSEÇÃO VIRAL: ANÁLISE DOS EFEITOS NEUROLÓGICOS PÓS-COVID NO SISTEMA NERVOSO
    Aléxia Stefani Siqueira Zetum, Danielle Ribeiro Campos da Silva, Giulia Maria Giacinti, Elizeu Fagundes de Carvalho, Débora Dummer Meira, Iúri Drumond Louro · 2024
  46. OS EFEITOS DA CL EM OUTROS SISTEMAS CORPORAIS
    Giulia Maria Giacinti, Aléxia Stefani Siqueira Zetum, Flávio dos Santos Alvarenga, Yasmin Moreto Guaitolini, Lorena Souza Castro Altoé, Elizeu Fagundes de Carvalho, Débora Dummer Meira, Iúri Drumond Louro · 2024
  47. INTRODUÇÃO
    Aléxia Stefani Siqueira Zetum, Giulia Maria Giacinti, Felipe Ataides Mion, Lorena Souza Castro Altoé, Elizeu Fagundes de Carvalho, Débora Dummer Meira, Iúri Drumond Louro · 2024
  48. COVID-19 E O SISTEMA IMUNOLÓGICO
    Aléxia Stefani Siqueira Zetum, Giulia Maria Giacinti, Yasmin Moreto Guaitolini, Felipe Ataides Mion, Lorena Souza Castro Altoé, Elizeu Fagundes de Carvalho, Débora Dummer Meira, Iúri Drumond Louro · 2024
  49. EFEITOS DA COVID LONGA NO SISTEMA CARDIORRESPIRATÓRIO
    VDP Ventorim, Giulia Maria Giacinti, Aléxia Stefani Siqueira Zetum, Lorena Souza Castro Altoé, Elizeu Fagundes de Carvalho, Débora Dummer Meira, Iúri Drumond Louro · 2024
  50. Além da pandemia: desvendando a covid longa e suas múltiplas facetas
    Elizeu Fagundes de Carvalho, Sônia Groisman, Iúri Drumond Louro, Débora Dummer Meira · 2024
  51. QUALIDADE DE VIDA PÓS-PANDEMIA: AVALIANDO IMPACTOS E RECUPERANDO O BEM-ESTAR
    Livia Cesar Morais, Henrique Perini Rosa, Aléxia Stefani Siqueira Zetum, Giulia Maria Giacinti, Karen Ruth Michio Barbosa, Lorena Souza Castro Altoé, Elizeu Fagundes de Carvalho, Débora Dummer Meira, Iúri Drumond Louro · 2024
  52. Longitudinal Dynamics of Immune Response in Occupational Populations Post COVID-19 Infection in the Changning District of Shanghai, China
    Li Li, Fengge Wang, Xiaoding He, Tingting Pei, Jiani Lu, Zhan Zhang, Ping Zhao, Jiayu Xue, Lin Zhu, Xinxin Chen et al. · 2024 · Viruses
  53. Characteristics, Outcomes, and Associations of Venous Thromboembolism in Diabetic Patients Infected With COVID-19 in Riyadh, Saudi Arabia
    Mansour S Albabtain, Khalid Alyousef, Ziad Mofareh Alharbi, Mohammed N Almutairi, Dunia M. Jawdat · 2024 · Cureus
  54. Microbiome and the COVID-19 pandemic
    Purvi R. Patel, M. Bhattacharjee · 2024 · Elsevier eBooks
  55. Prescription rates in different groups of outpatients with covid-19 and other acute respiratory infections: comparative observational study based on German routine data
    Lena Marie Paschke, Kerstin Klimke, Maike Below · 2025 · BMJ Medicine
  56. WITHDRAWN: Longterm Impact of COVID-19 in Hospitalized and Ambulatory Jamaican Children
    Samantha Ann-Patrice Mosha Miller, Mark Daniel Hicar, Crista-Lee Shahine Berry, Kathryn B. Anderson, J.L.M. Lindo, Gene D. Morse, C D C Christie · 2025 · medRxiv
  57. Additional file 6 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare
  58. Additional file 2 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare
  59. Additional file 1 of Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study
    Calcaterra, Valeria, Veronica Maria Tagi, D’Auria, Enza, Lai, Alessia, Sara Zanelli, Montanari, Chiara, Biganzoli, Elia Maria, Giuseppe Marano, Borghi, Elisa, Valentina Massa et al. · 2024 · Figshare
  60. Additional file 7 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare
  61. Additional file 8 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare
  62. Additional file 1 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2023 · Figshare
  63. Additional file 5 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare
  64. Additional file 4 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare
  65. Additional file 3 of Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Cheung, Angela Man-Wei, Eustache Paramithiotis et al. · 2024 · Figshare